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https://doi.org/10.1016/j.stemcr.2018.12.010SUMMARYRetinal ganglion cells (RGCs) form the connection between the eye and the brain, with this connectivity disrupted in numerous blinding
disorders. Previous studies have demonstrated the ability to derive RGCs fromhuman pluripotent stem cells (hPSCs); however, these cells
exhibited some characteristics that indicated a limited state of maturation. Among the many factors known to influence RGC develop-
ment in the retina, astrocytes are known to play a significant role in their functional maturation. Thus, efforts of the current study exam-
ined the functional maturation of hPSC-derived RGCs, including the ability of astrocytes to modulate this developmental timeline.
Morphological and functional properties of RGCs were found to increase over time, with astrocytes significantly accelerating the func-
tional maturation of hPSC-derived RGCs. The results of this study clearly demonstrate the functional and morphological maturation of
RGCs in vitro, including the effects of astrocytes on the maturation of hPSC-derived RGCs.INTRODUCTION
Human pluripotent stem cells (hPSCs) have emerged as an
advantageous in vitro model for studying neural develop-
ment and neurodegeneration, as these cells can be differen-
tiated into any cell type of the body, including those of the
nervous system (Corti et al., 2015; Jin et al., 2011; Marche-
tto et al., 2011;Meyer et al., 2009; Takahashi et al., 2007; Yu
et al., 2007). Moreover, when derived from patient-specific
sources, hPSCs can serve as powerful tools for disease
modeling as well as large-scale pharmacological screens
(Ebert and Svendsen, 2010; Grskovic et al., 2011; Inoue
and Yamanaka, 2011). However, for hPSCs to effectively
serve in these applications, they must closely mirror the
phenotypic and functional features of the affected cell
type. Retinal ganglion cells (RGCs) form the essential
connection between the eye and the brain, allowing for
visual transduction and the ability to see. This important
connection becomes severed in numerous blinding disor-
ders termed optic neuropathies, which cause progressive
degeneration and eventual death of RGCs in the retina
(Almasieh et al., 2012; You et al., 2013).
Previous studies have demonstrated the ability to suc-
cessfully differentiate RGCs from hPSCs in an efficient
and reproducible manner (Fligor et al., 2018; Gill et al.,
2016; Langer et al., 2018; Maekawa et al., 2016; Ohle-
macher et al., 2016; Riazifar et al., 2014; Sluch et al.,
2015; Tanaka et al., 2015; Teotia et al., 2017). RGCs derived
using such methods have recapitulated the developmentalStem Cell Re
This is an open access article under the Ctiming of the retina, as well as displaying variousmolecular
and morphological characteristics similar to the in vivo cell
type. As the projection neuron of the retina, RGCs extend
long axons through the optic nerve to communicate visual
information to the brain. hPSC-derived RGCs have demon-
strated some capacity to exhibit predicted electrophysio-
logical characteristics, including the ability to fire action
potentials (APs), conduct ionic currents, and respond to
glutamate (Gill et al., 2016; Ohlemacher et al., 2016; Riazi-
far et al., 2014; Sluch et al., 2015; Tanaka et al., 2015; Teotia
et al., 2017). However, these studies have often demon-
strated somewhat limited functional properties of hPSC-
derived RGCs and have failed to take into consideration
themilieu of factors known to influence RGC development
and maturation. Among the more influential of these fac-
tors are contributions from astrocytes, which are known
to closely associate with RGCs in the nerve fiber layer and
optic nerve (Bussow, 1980; Vecino et al., 2016; Zuchero
and Barres, 2015).
As such, the current study focused on characterizing
the functional maturation of hPSC (both embryonic stem
and induced pluripotent stem)-derived RGCs based
upon morphological complexity and electrophysiological
properties, over time as well as in response to signaling
from astrocytes. Initially, hPSC-derived RGCs demon-
strated increased neurite complexity as a function of
time, including enlargement of the cell somas and elonga-
tion of neurites. In addition, these hPSC-derived RGCs dis-
played increasing ionic currents, AP excitability, and theports j Vol. 12 j 201–212 j February 12, 2019 j ª 2018 The Authors. 201
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expression of synaptic proteins. To study the influence of
astrocytes upon hPSC-derived RGC maturation, cells were
either plated in co-culture with hPSC-derived astrocytes
or supplemented with astrocyte conditioned medium
(ACM) to determine substrate-bound or secreted effects of
astrocytes on RGCs, respectively. RGCs co-cultured with as-
trocytes demonstrated expedited and enhanced morpho-
logical and functional characteristics compared with
RGCs cultured alone. The results of this study clearly
demonstrate the functional andmorphologicalmaturation
of RGCs in vitro as well as exploring how astrocytes modu-
late and expedite this maturation. These results will also
lead to the development ofmore realistic hPSC-derived dis-
ease models, with important implications for pharmaco-
logical screenings and cell replacement strategies in future
studies.RESULTS
Increased RGC Neurite Complexity Over Time
RGCs exhibit complex morphological features within the
retina, with long axons extending out of the eye through
the optic nerve, while a complex and extensive network
of dendrites reaches into the inner plexiform layer (Erskine
and Herrera, 2014; Masland, 2012; Sernagor et al., 2001).
Given this morphological complexity, an hPSC-derived
RGC population should also exhibit intricate features to
serve as an effective in vitro model. However, the study of
hPSC-derived RGC morphological features has been some-
what limited in previous studies, as RGCs are often differ-
entiated and examined in a mixed population of other
cell types (Lamba et al., 2010; Meyer et al., 2011; Sridhar
et al., 2013). In addition, the definitive identification of
RGCs within such cultures has been complicated by the
lack of unique, reliable markers that allow for the visualiza-
tion of entire RGCs, including their extensive neurites.
Thus, to overcome these issues, a CRISPR/Cas9-engineered
cell line with a tdTomato reporter andmouse Thy1.2 select-
able marker was used to identify and enrich for hPSC-
derived RGCs (Sluch et al., 2017).
In accordance with previous studies, hPSC-derived RGCs
could be readily observed within the first 40 days of differ-
entiation (Ohlemacher et al., 2016), at which point RGCs
were enriched and plated to allow for maturation and ex-
amination. Over the next 10 days, hPSC-derived RGCs dis-
played features of increasing neurite complexity, including
robust and complex neurite outgrowth (Figure 1). Purified
RGCs demonstrated a dramatic and significant increase in
soma size, more than doubling within the first 10 days of
growth (Figure 1J). In addition, RGC neurites grew signifi-
cantly in length over time, with neurites extending upward
of 150 mmwithin 10 days of plating (Figures 1F–1I and 1K).202 Stem Cell Reports j Vol. 12 j 201–212 j February 12, 2019The complexity of RGC neurites was examined and they
showed increasingly complexmorphologies, with the neu-
rite branch order more than doubling within this time
course (Figure 1L). RGCneurites also displayed a 13-fold in-
crease in the number of branchpoints within the first
10 days of growth (Figure 1M). As such, hPSC-derived
RGCs were capable of exhibiting increased morphological
complexity over time, including the enlargement of the
cell soma and elongation of complex neurites.
Functional Maturation of hPSC-Derived RGCs Over
Time
Within the retina, RGCs are the most excitable cells, with
the nearly exclusive ability to fire APs necessary for the
propagation of visual signals to the brain (Erskine and Her-
rera, 2014; Gao andWu, 1999; Guenther et al., 1999; Meis-
ter et al., 1991; Sernagor et al., 2001; Tian et al., 1998;Wang
et al., 1997). As such, efforts were undertaken to examine
the electrophysiological features of hPSC-derived RGCs,
as well as how these characteristics change over time (Fig-
ure 2). Voltage-clamp recordings from hPSC-derived
RGCs exhibited an increase in peak sodium conductance
as neurons matured from 1 to 4 weeks (Figure 2A). The cur-
rent-voltage relationship (I-V curve; Figure 2B) displayed
increased sodium currents with the average peak current
increasing over time. The voltage dependence of activation
for normalized peak sodium conductance showed a signif-
icant hyperpolarized shift as the RGCs matured from week
1 to week 2 and further (Figure 2C), signifying functional
maturation of hPSC-derived RGCs that is consistent with
the developmental shift observed in rat and mouse RGCs
(Rothe et al., 1999; Schmid and Guenther, 1998). Current
density plots also displayed an increase in sodium currents
from 1 to 4 weeks of RGC maturation, indicating an in-
crease in the expression of voltage-gated sodium channels
(Figure 2D).
Subsequently, the ability of hPSC-derived RGCs to fire
spontaneous APs was examined, with no spontaneous
activity detected after 1 week, but with spontaneous APs
elicited as early as 2 weeks (Figure 3A). By 4 weeks, repeti-
tive AP firing patterns emerged, along with occasional AP
bursts. The percentage of hPSC-derived RGCs capable of
spontaneous AP firing was found to continually increase
from 1 to 4 weeks (Figure 3B). Furthermore, the average
number of spontaneous APs fired increased significantly
as hPSC-derived RGCs matured (Figure 3C).
To determine if hPSC-derived RGCs were capable
of forming presumptive synaptic contacts, the expression
of various synaptic proteins was analyzed from 1 to 3 weeks
following purification (Figure 4). hPSC-derived RGCs
demonstrated a significant increase in the number of SV2-
positive puncta along their neurites from 1 to 3 weeks (Fig-
ures 4A–4D). In addition, western blot analyses revealed
Figure 1. Temporal Acquisition of Com-
plex Neuronal Morphologies by hPSC-
Derived RGCs
(A) Representative timeline for the experi-
mental differentiation and analysis of hPSC-
derived RGCs.
(B–I) Immunocytochemistry (ICC) and
representative tracings of hPSC-derived
RGCs at 1 (B and F), 4 (C and G), 7 (D and H),
and 10 days (E and I) post-purification
displayed enhanced morphological matu-
ration over time. RGC tracings in (F–I)
represent neurites observed at 203
magnification, which allowed for the ability
to image the entire cell, but due to the
small diameter of the neurites, this level of
magnification limited their ability to be
readily observed in microscopy images.
(J) The area of RGC somas significantly
increased over time.
(K) The average neurite length of hPSC-
derived RGCs significantly increased from 1
to 10 days.
(L and M) Last, neurite tracings demon-
strated a significant increase in (L) neurite
order complexity and (M) number of
branches within 10 days of purification.
Scale bars, 30 mm. Error bars represent SEM
(n = 5 independent replicates for each bar
using H7, tiPS5, and miPS2 cell lines) and
significance was determined using a 95%
confidence interval; *p < 0.05, **p < 0.01,
***p < 0.001, ****p < 0.0001.an increased expression of synaptic proteins over time,
including Synapsin-1, vGlut2, Neurexin-1, and SNAP25
(Figures 4E and 4F). Taken together, these data reveal
that hPSC-derived RGCs exhibited electrophysiological
properties and formed presumptive synaptic contacts as
predicted by in vivo studies, with these features increasing
over time.
AstrocytesModulate theMorphological Complexity of
hPSC-Derived RGCs
Within the retina, astrocytes are closely associated with
RGCs within the nerve fiber layer and optic nerve, where
they are known to support RGCs through the release of
growth factors and reuptake of neurotransmitter and bymaintaining ionic balances, among other roles (Allen and
Barres, 2009; Barres, 1991; Ogden, 1978; Pellerin and Mag-
istretti, 1994; Vecino et al., 2016;Wordinger et al., 2003). In
addition, astrocytes have been shown to modulate the
maturation of a variety of neuronal cell types and influence
their synaptic development in vitro (Johnson et al., 2007;
Odawara et al., 2014). However, similar experiments have
not tested their ability to influence RGC development
andmaturation. As such, co-cultures with hPSC-derived as-
trocytes were developed as a strategy to enhance the matu-
ration of hPSC-derived RGCs.
hPSCs were differentiated into an astrocytic lineage
(Krencik and Zhang, 2011), yielding highly enriched popu-
lations of GFAP-positive astrocytes after 9 months ofStem Cell Reports j Vol. 12 j 201–212 j February 12, 2019 203
Figure 2. Temporal Development of
Functional Maturation of hPSC-Derived
RGCs
(A) Patch-clamp recordings revealed an in-
crease in inward ionic currents within
4 weeks of purification.
(B) From 1 to 4 weeks, I-V curves displayed
increased inward current as RGCs matured.
(C) Voltage dependence of activation indi-
cated a significant shift in the hyper-
polarized direction over time.
(D) A current density plot demonstrated a
significant increase in sodium currents over
4 weeks.
(E) A table representing the increases in
peak conductance, midpoints of activation,
and current density values at each time
point.
Error bars represent SEM (n > 4 independent
replicates for each bar using H7, tiPS5, and
miPS2 cell lines) and significant differences
are indicated as *p < 0.05, ***p < 0.001,
****p < 0.0001.growth (Figure S1). In addition, these astrocyte populations
also expressed a multitude of other glial cell markers,
including Vimentin, S100b, SOX2, and Nestin (Figures
S1C–S1E). The ability of these hPSC-derived astrocytes to
support RGCs was also suggested by the expression of
Excitatory Amino Acid Transporter 1 (EAAT1), important
for the reuptake of excess glutamate at the synapse (Fig-
ure S1F). To establish a co-culture system with which to
directly study the interactions between astrocytes and
RGCs, hPSC-derived RGCswere purified and plated in asso-
ciation with hPSC-derived astrocytes and grown in co-cul-
ture for 10 days to observe changes in RGC morphology
and neurite outgrowth (Figure S1G). In addition, to sepa-
rate the effects of astrocytes as either substrate-bound or
due to soluble factors secreted into the medium, hPSC-
derived RGCs were separately supplemented with ACM.
After 10 days of plating, purified RGCs co-cultured
with astrocytes displayed significant and robust neurite
outgrowth and complexity compared with RGCs grown
alone or supplemented with ACM (Figures 5A–5F). Astro-
cyte co-cultures led to significant increases in RGC soma
size as well as the average length of the longest neurite,
while ACM showed no significant effects (Figures 5G and
5H). Moreover, RGCs co-cultured with astrocytes displayed
significantly more complex neurite outgrowth as indicated
by the number of primary, secondary, tertiary, and quater-
nary neurites and number of branchpoints (Figures 5I and204 Stem Cell Reports j Vol. 12 j 201–212 j February 12, 20195J). As supplementing RGCswith ACM led to no significant
changes in morphological analyses, subsequent experi-
ments examined the effects of astrocytes solely through
direct contact in co-cultures.
Astrocytes Accelerate the Functional Maturation of
hPSC-Derived RGCs
Next, the effects of astrocyte co-cultures on the functional
maturation of hPSC-derived RGCswere characterized. Elec-
trophysiological analyses of the evoked APs were conduct-
ed on both the RGCs grown alone and those co-cultured
with astrocytes at 3 weeks post-purification (Figures 6A–
6D). Quantitatively, RGCs co-cultured with astrocytes
demonstrated an increased number of AP firings (Fig-
ure 6E), in response to a steady current injection as well
as in response to a ramp depolarization event. In addition,
the presence of astrocytes in co-culture with hPSC-derived
RGCs increased the AP amplitude (Figure 6F) and decreased
the AP duration (Figure 6G) compared with RGCs cultured
alone. Furthermore, RGCs co-cultured with astrocytes
showed a more hyperpolarized AP threshold (Figure 6H).
In addition, the ability of astrocytes to enhance the forma-
tion of presumptive synaptic contacts was assessed by
comparing RGCs grown alone with RGCs co-cultured with
astrocytes. RGCs grown with astrocytes displayed a signifi-
cantly higher number of SV2-positive presumptive synaptic
puncta at 10 days post-purification (Figures 7A–7C), similar
Figure 3. Increased Excitability of hPSC-Derived RGCs Occurs in
a Temporally Dependent Manner
(A) Patch-clamp recordings demonstrated the increased ability of
hPSC-derived RGCs to fire spontaneous APs from 1 to 4 weeks post-
purification.
(B) The percentage of spontaneous APs that increased between
1 (n = 12), 2 (n = 22), 3 (n = 16), and 4 (n = 17) weeks.
(C) Spiking behavior of hPSC-derived RGCs from 1 to 4 weeks
significantly increased.
Error bars represent SEM (n > 12 independent replicates for each bar
using H7, tiPS5, and miPS2 cell lines) and significant differences
are indicated as *p < 0.05.
Figure 4. Formation of Presumptive Synaptic Contacts by hPSC-
Derived RGCs
(A–C) ICC demonstrated the increased presence of SV2 puncta
within hPSC-derived RGC neurites at (A) 1, (B) 2, and (C) 3 weeks
post-purification.
(D) The number of SV2 puncta per neurite length significantly
increased over time.
(E and F) Western blot analyses displayed expression of a number of
synaptic proteins (E) with densitometry measurements exhibiting
increased expression over time (F).
Scale bars, 20 mm. Error bars represent SEM (n = 3 independent
replicates for each bar using H7, tiPS5, and miPS2 cell lines) and
significant differences were determined at a 95% confidence in-
terval; *p < 0.05, **p < 0.01, ****p < 0.0001.to that observed for RGCs plated alone at 3 weeks post-puri-
fication (Figures 4A–4D). Analyses of spontaneous synaptic
currents revealed that RGCs co-cultured with astrocytes
also exhibited more frequent spontaneous inward ionic
currents (Figure 7D). Furthermore, western blot analyses re-
vealed that RGCs grown in co-culture with astrocytes
demonstrated significantly increased expression of a variety
of synaptic proteins (Figures 7E and 7F). Additional western
blot analysis confirmed that increased synaptic protein
expression in co-cultures was a result of increased RGC
maturation and not derived from astrocyte populations
(Figure S2).DISCUSSION
The utilization of hPSCs to study RGCs has been more
recently studied with an important emphasis on how these
cells can serve as a translationalmodel for the development
of RGCs as well as diseases resulting in degeneration and
eventual death of these cells (Corti et al., 2015; Gaillard
and Sauve, 2007; Jin et al., 2011). However, to date, studiesof hPSC-derived RGCs have often shown limited func-
tional capabilities and have overlooked the interactions
of many other cell types closely associated with RGCs in
the retina that can play a vital role in the development
and maturation of these cells (Bussow, 1980; Vecino
et al., 2016). As RGCs form the essential connection be-
tween the eye and the brain, these cells demonstrate a
number of morphological and functional characteristics
unique to RGCs within the retina, including the extension
of long and complex neurites and the ability to fire APs
(Guenther et al., 1999; Hebel and Hollander, 1983; Serna-
gor et al., 2001; Wang et al., 1997). The generation of
hPSC-derived RGCs, which recapitulate these distinctive
characteristics, would allow for a more representative
model of these cells, with important implications for how
these cells can serve as a tool for disease modeling, drug
screenings, and future cell replacement therapies. The re-
sults of this study demonstrate the derivation of RGCs
that exhibit characteristics closely resembling their in vivo
counterparts, allowing for a greater understanding of howStem Cell Reports j Vol. 12 j 201–212 j February 12, 2019 205
Figure 5. Astrocytes Expedite and
Enhance the Morphological Maturation
of hPSC-Derived RGCs
(A–F) At 10 days post-purification, ICC and
representative neurite tracings of hPSC-
derived RGCs displayed enhanced morpho-
logical maturation for (C and F) RGCs grown
with astrocytes compared with (A and D)
RGCs grown alone or (B and E) RGCs sup-
plemented with ACM.
(G and H) Significant increases were
observed in (G) soma size area and (H) the
length of the longest neurite for hPSC-
derived RGCs grown with astrocytes.
(I and J) Neurite tracings displayed a
significant increase in (I) neurite order
complexity and (J) number of branches for
hPSC-derived RGCs on astrocytes compared
with other conditions.
Scale bars, 50 mm. Error bars represent SEM
(n = 5 independent replicates for each bar
using H7, H9, tiPS5, and miPS2 cell lines)
and significant differences were determined
at a 95% confidence interval; *p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.0001.these cells develop and may be affected in disease states.
Furthermore, the ability to extensively study the morpho-
logical and functional maturation of hPSC-derived RGCs
over time demonstrates their ability to acquire advancing
features of RGC maturation, with astrocytes significantly
expediting and enhancing this maturation.
RGCs are the main cell type affected in numerous blind-
ing disorders that result in the degeneration and death of
these cells, leading to loss of vision and eventual blindness
(Almasieh et al., 2012; Quigley, 2011; You et al., 2013).
Therefore, the use of hPSC-derived RGCs allows for the
establishment of translational models of these diseases to206 Stem Cell Reports j Vol. 12 j 201–212 j February 12, 2019understand mechanisms causing the death of RGCs, as
well as for the development of treatments and therapeutics
targeting these disease phenotypes, including large-scale
pharmaceutical screenings and potential cell replacement
strategies. However, for hPSC-derived RGCs to serve as
a reliable disease model, they must closely mimic the
phenotypic and functional characteristics of the affected
cell type, as disease states often manifest in fully differ-
entiated and functionally mature cells. In the current
study, hPSC-derived RGCs exhibited increasedmorpholog-
ical complexity and functional maturation over time,
including increasing inward ionic currents and the more
Figure 6. hPSC-Derived Astrocytes Modulate the Functional
Maturation of hPSC-Derived RGCs
(A and B) Patch-clamp recordings demonstrated the heightened
excitability of (B) hPSC-derived RGCs grown on astrocytes
compared with (A) hPSC-derived RGCs grown alone.
(C and D) A ramp depolarization indicated the ability of (D) hPSC-
derived RGCs grown with astrocytes to fire more and repetitive APs
compared with (C) RGCs alone.
(E–H) hPSC-derived RGCs grown with astrocytes exhibited (E) a
higher number of APs fired, (F) increased amplitude, (G) decreased
duration, and (H) a more hyperpolarized AP threshold.
Error bars represent SEM (n = 8 independent replicates for each bar
using H7, H9, tiPS5, and miPS2 cell lines) and significance was
determined at a 95% confidence interval; **p < 0.01, ****p <
0.0001.frequent firing of spontaneous APs, with these features
becoming significantly enhanced in the presence of astro-
cytes. The demonstration of these advancing features of
RGCmaturation thus allows for the ability to use these cells
as a more faithful model for studying diseases affecting thehealth of RGCs, as well as aiding in the development of
therapeutic strategies to target disease mechanisms.
A number of previous studies have demonstrated the
ability to derive RGCs from hPSCs, with several of these
studies establishing that these RGCs may possess a range
of functional properties, including ionic currents, firing
of APs, and response to glutamate (Gill et al., 2016; Ohle-
macher et al., 2016; Riazifar et al., 2014; Sluch et al.,
2015; Tanaka et al., 2015; Teotia et al., 2017). However,
these results often indicated a degree of immaturity of these
cells, and seldom examined their functional properties
beyond a single time point post-purification. Results of
the current study showed hPSC-derived RGCs over multi-
ple time points, demonstrating progressive features of their
development and growth as they differentiated through
various stages of morphological and functional maturity.
By 3 weeks, hPSC-derived RGCs were capable of con-
ducting substantial inward ionic currents with a hyperpo-
larized voltage dependence of activation, firing trains of
spontaneous APs, and expressing a variety of synaptic
proteins, all characteristics consistent with a functionally
mature RGC. The study of hPSC-derived RGCs in such a
manner allows for their use as a more appropriate develop-
mental model.
RGCs are the projection neuron of the retina forming the
vital connection between the eye and the brain, doing so
by extending long and intricate axons through the optic
nerve as well as forming complex connections with retinal
interneurons within the inner plexiform layers (Masland,
2012). The analysis of various morphological properties
within 10 days demonstrated a significant increase in the
length and complexity of hPSC-derived RGC neurites
over time. Similarly, hPSC-derived RGC somas were shown
to significantly increase in area over time, comparable with
many RGCs found in vivo (Liu et al., 2017). Taken together,
these results indicated the ability of hPSC-derived RGCs to
acquire advancing features of morphological maturation
and, as such, establish hPSC-derived RGCs as a more reli-
able model of RGC development.
RGCs form synaptic contacts both in the retina and in
the brain, with pre-synaptic contacts formed with bipolar
and amacrine cells in the inner plexiform layer, and post-
synaptic contacts formed with targets including the lateral
geniculate nucleus and the superior colliculus (Herrera
et al., 2017; Martersteck et al., 2017). The presence of syn-
aptic features within hPSC-derived RGCs would thus serve
as an additional measure of their maturation and, likewise,
their effectiveness as an in vitromodel. A number of synap-
tic proteins were found to be expressed by hPSC-derived
RGCs over time, indicating the formation of presumptive
synaptic contacts. The expression of these proteins was
found to increase over time, indicating the acquisition of
advancing features of maturation. The prospective abilityStem Cell Reports j Vol. 12 j 201–212 j February 12, 2019 207
Figure 7. Astrocytes Regulate the Synaptic Maturation of hPSC-
Derived RGCs
(A and B) At 10 days post-purification, ICC demonstrated the
increased presence of SV2 puncta within (B) hPSC-derived RGC
neurites grown in the presence of astrocytes compared with (A)
those grown alone.
(C) The number of SV2 puncta significantly increased in hPSC-
derived RGCs grown with astrocytes.
(D) Patch-clamp recordings demonstrated an increase in the
number and frequency of spontaneous post-synaptic currents for
RGCs grown with astrocytes.
(E and F) Western blot analyses displayed expression of a number of
synaptic proteins when hPSC-derived RGCs were grown with astro-
cytes (E) with densitometry measurements exhibiting increased
expression compared to RGCs grown alone (F).
Scale bars, 20 mm. Error bars represent SEM (n = 3 independent
replicates for each bar using H7, H9, tiPS5, and miPS2 cell lines)
and significance was determined at a 95% confidence interval;
****p < 0.0001.of these hPSC-derived RGCs not only contributes to their
effectiveness as an appropriate in vitro model, but may
also enable their use for cellular replacement if they are
capable of incorporating into a neural network.
While hPSC-derived RGCs exhibited numerous features
of maturation, many other cell types are known to play a
role in this process in vivo. Astrocytes are found in close as-
sociation with RGCs in the nerve fiber layer of the retina as
well as within the optic nerve (Vecino et al., 2016). These
cells provide support to RGCs in a number of ways,
including the regulation ionic concentrations, the reup-
take of excess neurotransmitters, and the release of various
growth factors (Clarke and Barres, 2013; Eroglu and Barres,208 Stem Cell Reports j Vol. 12 j 201–212 j February 12, 20192010; Pellerin and Magistretti, 1994; Pfrieger and Barres,
1997; Ullian et al., 2004). Therefore, the interaction of
these two cell types could enhance the maturation of
hPSC-derived RGCswhen grown in a co-culture. In the cur-
rent study, the ability of astrocytes to modulate RGCmatu-
ration was examined, with effects possibly due to the
release of soluble factors or through direct contact between
astrocytes and RGCs. hPSC-derived RGCs grown in direct
contact with astrocytes displayed expedited and signifi-
cantly enhanced morphological and functional matura-
tion compared with RGCs grown alone or in the presence
of astrocyte-derived soluble factors tested with ACM,
including the extension of longer and more complex neu-
rites as well as the ability to fire APs. As soluble factors
tested by ACM did not demonstrate any significant differ-
ences compared with control experiments, the effects
observed via direct contact with astrocytes could poten-
tially be explained by multiple factors. The development
of gap junctions between astrocytes and RGCs could allow
for communication between these cell types, although pre-
liminary data indicated a lack of expression of Connexin 43
in these cultures (data not shown), likely due to a some-
what immature stage of differentiation. Alternatively, these
maturation-enhancing effects could be due to the activa-
tion of signaling pathways triggered through substrate-
bound ligands found on the astrocytic cell membrane.
Regardless, these results established the importance of
direct contact between hPSC-derived RGCs and hPSC-
derived astrocytes, which more accurately represents an
environment similar to that of the retina and optic nerve.
One the most profound effects of astrocytes upon hPSC-
derived RGCs was the enhancement of their electrophysio-
logical properties. When grown with astrocytes, these cells
had a higher level of activity, including increased firing of
APs and presumptive synaptic currents. In addition, these
characteristics were often easier to elicit in the presence
of astrocytes as indicated by the injection of smaller
amounts of current, indicating a heightened excitability
of hPSC-derived RGCs. Taken together, these results indi-
cated that co-culturing astrocytes with hPSC-derived
RGCs created an expedited and enhanced degree of matu-
ration compared with RGCs cultured alone. Moreover,
RGCs co-cultured with astrocytes generated a cell type
more closely resembling in vivo RGCs with the ability to
extend significantly longer and more intricate neurites,
fire repetitive APs, and form presumptive synaptic con-
tacts. In future studies, numerous variables will need to
be considered to establish the full functionality of hPSC-
derived RGCs, as many factors influence the growth and
maturation of RGCs in vivo, including other glial cells,
the blood-brain barrier, as well as the establishment of
both pre- and post-synaptic contacts. As such, while the
current study clearly demonstrates the ability of astrocytes
to enhance maturation of hPSC-derived RGCs, additional
efforts will be needed in the future to elucidate cellular
and molecular contributors to RGC maturation approach-
ing that of endogenous RGCs. The ability tomore faithfully
emulate the RGC environmentwithin the retina is also crit-
ical for the establishment of cellular replacement strategies,
as transplanted RGCs would encounter a variety of factors
influencing their integration and growth in vivo that would
not typically be recapitulated in an in vitro setting. Thus,
the current studies represent a model that more closely
mimics the in vivo environment for RGCs, facilitating
future studies for cellular replacement.
Overall, the results of the current study indicate the
important contributions of astrocytes to RGCdevelopment
and maturation. In future studies, the role of astrocytes
should be considered in the establishment of develop-
mental and disease models utilizing RGCs. The interaction
of astrocytes with RGCs would allow for the development
of a more mature cell type that can be used to properly
identify and further understand disease deficits affecting
RGCs. Moreover, given the important role of astrocytes in
RGC maturation and function, future studies should also
focus on the contributions of astrocytes to disease states
and if diseased astrocytes are playing a role in the degener-
ation of RGCs. Furthermore, given their importance in the
maturation and homeostasis of RGCs, astrocytes may pro-
vide an alternative target for therapeutics for optic neurop-
athies, and serve as a target for cell replacement strategies in
future studies to enhance the survival and function of
endogenous RGCs.EXPERIMENTAL PROCEDURES
Maintenance of hPSCs
hPSCs were grown as previously described (Ohlemacher et al.,
2015). Multiple hPSC lines were used throughout this study,
including H7 (Thomson et al., 1998), H9 (Thomson et al., 1998),
TiPS5 (Phillips et al., 2012), and miPS2 (Sridhar et al., 2016). In
short, hPSCs were maintained in the undifferentiated state using
human embryonic stem cell-qualified Matrigel (Corning) on six-
well plates with mTeSR1 medium (STEMCELL Technologies) at
37C and 5% CO2. Passaging of hPSCs was accomplished by enzy-
matically lifting colonies using dispase (2 mg/mL) for approxi-
mately 15 min. Colonies were then mechanically disrupted to
yield small aggregates of cells and split at a 1:6 ratio.
Differentiation of hPSCs into RGCs
hPSCs were differentiated to a retinal fate using previously
described protocols with minor modifications (Ohlemacher
et al., 2015). After 30 days of differentiation, early retinal organoids
could be morphologically identified and isolated apart from other
forebrain neurospheres. At day 45, retinal organoids were dissoci-
ated using Accutase for 20 min at 37C. Following dissociation,
single cells were immunopurified for RGCswith the Thy1.2 surfacereceptor using the MACS magnetic cell separation kit (Miltenyi
Biotec). Briefly, dissociated cells were incubated with CD90.2 mi-
crobeads for 15 min at 4C in the dark at a ratio of 10 mL of
beads:90 mL of MACS rinsing buffer per 10 million cells (Sluch
et al., 2017). Purified RGCs were then plated on poly-D-ornithine
and laminin-coated coverslips at a density of 10,000 cells/coverslip
andmaintained in BrainPhys neuronal medium (STEMCELLTech-
nologies) supplemented with 20 ng/mL CNTF. Coverslips were
then fixed at indicated time points post-plating to analyze RGC
maturation, or utilized for subsequent patch-clamp recordings.
Astrocyte Differentiation from hPSCs
hPSCs were differentiated to astrocytes using previously described
protocols (Krencik and Zhang, 2011). Within 40 days of differenti-
ation, early neurospheres were supplemented with 20 ng/mL EFH
(FGF2 and EGF) to induce proliferation to a gliogenic phase. Neu-
rospheres were chopped and expanded using a mechanical tissue
chopper to a size of 200 mm every 2 weeks for up to 12months. Be-
tween 9 and 12 months, neurospheres became enriched for astro-
cytes and were then dissociated using Accutase for 20min at 37C.
Single cells were plated at a density of 20,000 astrocytes per 12mm
coverslip and supplemented with BrainPhys neuronal medium
with the addition of 20 ng/mL CNTF to yield GFAP-positive astro-
cytes within 3 weeks of plating. Subsequently, co-cultures of RGCs
and astrocytes were established with 10,000 purified RGCs plated
with adhered astrocytes to create a substrate-bound co-culture. In
addition, ACM was collected from plated astrocytes, filtered to re-
move cellular components, and added every other day to RGC
cultures at a dilution of 1:1 together with fresh BrainPhys as
previously described (Pfrieger and Barres, 1997). Co-culture exper-
iments were fixed at indicated time points post-plating and
analyzed for RGCmaturation, or utilized for patch-clamp analysis.
Immunocytochemistry
Samples were fixed with 4% paraformaldehyde for 30 min and
then washed three times with phosphate-buffered saline (PBS).
Cells were then permeabilized in 0.2% Triton X-100 for 10 min
at room temperature, followed by blocking in 10% donkey serum
for 1 hr at room temperature. Primary antibodies (Table S1) were
diluted in 5% donkey serum and 0.1% Triton X-100 solution and
applied to samples overnight at 4C. The following day, cells
were washed three times with PBS and blocked with 10% donkey
serum for 10 min at room temperature. Secondary antibodies
were diluted in 5% donkey serum and 0.1% Triton X-100 solution
and added for 1 hr at room temperature. The cells were then
washed three times with PBS and mounted onto slides for micro-
scopy. Immunofluorescence images were obtained using a Leica
DM5500 fluorescence microscope.
Quantification and Statistical Analyses
Samples were analyzed for RGC maturation based on soma size,
neurite length, and complexity. Numerous biological replicates
(n = 5) were obtained at each time point. Immunofluorescence im-
ages were taken and analyzed for the expression of tdTomato to
identify RGCs. The RGC soma size area, neurite length, and branch
order were quantified and recorded using ImageJ. Statistical ana-
lyses were performed using one-way ANOVA followed by Tukey’sStem Cell Reports j Vol. 12 j 201–212 j February 12, 2019 209
post hoc. Statistical differenceswere determined based on a p value
of less than 0.05. In addition, the abundance of SV2 puncta was
quantified using ImageJ, with the total neurite length associated
with SV2 immunoreactivity quantified using the ImageJ plugin
NeuronJ. Statistical analyses were performed using one-way
ANOVA followed by Tukey’s post hoc for SV2 expression in RGCs
alone over time and Student’s t test for comparing SV2 expression
in RGCs to that in RGCs grownon astrocytes. Statistical differences
were determined based on a p value of less than 0.05.Western Blot
RGCs were collected and sonicated in a 2% SDS solution. Protein
concentration was determined using a BCA assay (Thermo Scienti-
fic) and samples were normalized so that equal amounts of protein
were loaded into each well. Lysates were mixed with 43 sample
buffer plus DTT and loaded onto 4%–15% gradient gels. Gels
were transferred to nitrocellulose using the Trans-Blot Turbo sys-
tem (Bio-Rad), blocked with 5% milk in Tris-buffered saline (TBS)
plus 0.1% Tween 20, and blotted with primary antibodies (Table
S1) overnight at 4C. After a wash with 5% milk in TBS plus
0.1% Tween 20, secondary antibody was applied for 1 hr using
donkey anti-mouse 790 or donkey anti-rabbit 790 (Jackson Immu-
noResearch). Blots were washed with TBS and imaged using the
LI-COR Odyssey CLx imaging system (LI-COR Biosciences). For
the synaptic maturation of RGCs over time, histone H3 was used
as a loading control. Fluorescence intensity was calculated for
each band and normalized to histone H3 at week 1. A fold change
was generated by dividing each normalized value for each synaptic
protein by the normalized intensity at week 1 (n = 3). For RGCs
grown alone or with astrocytes, BRN3B was used as a loading
control to normalize to RGC-specific protein. Normalized relative
fold changes for synaptic proteins were calculated by dividing
the BRN3B normalized fluorescence intensity of each of the two
groups by that of the RGCs grown alone (n = 3).Electrophysiological Recordings
Whole-cell patch-clamp recordings were made at room tempera-
ture (21C) using a HEKA EPC 10 amplifier and Patchmaster data
acquisition software (HEKA). Recording pipettes with a tip resis-
tance of 4–7 MU were fabricated from borosilicate capillary glass
(1.2 mm outer diameter, 0.60 mm inner diameter; Sutter Instru-
ment Co.) using a P-1,000 puller (Sutter InstrumentCo.). The bath-
ing solution contained NaCl 140 mM, MgCl2 1 mM, KCl 5 mM,
CaCl2 2 mM, HEPES 10 mM, glucose 10 mM (pH 7.3 adjusted
with NaOH). For current-clamp recordings pipettes were filled
with internal solution containing KCl 140 mM, MgCl2 5 mM,
CaCl2 2.5 mM, EGTA 5 mM, HEPES 10 mM (pH 7.3 adjusted
with KOH), and for voltage-clamp recordings the internal solution
contained CsF 130 mM, NaCl 10 mM, HEPES 10 mM, CsEGTA
(EGTA in CsOH) 1 mM. Inward sodium currents were recorded
in voltage-clampmode with a holding potential of80 mV. Spon-
taneous AP activity was recorded in current-clamp mode at 0 pA
immediately after establishing whole-cell configuration. For
evoked APs, the cells were allowed to stabilize in the whole-cell
configuration for 2 min before initiation of either step current in-
jections with incremental steps of 2 pA up to 40 pA (pulse duration
of 500ms) or ramp current injection with depolarization from 0 to210 Stem Cell Reports j Vol. 12 j 201–212 j February 12, 201940 pA for 1 s (Vhold = 80 mV). AP threshold was estimated from
the first evoked spike using ramp current injection and was calcu-
lated using the dV/dt method. AP amplitude was measured as
height of the peak from threshold and AP duration was measured
as width at the threshold.Whennecessary, a small bias currentwas
injected to maintain a similar baseline membrane potential
(near 70 mV) before depolarizing current injections. Sponta-
neous post-synaptic currents were measured in the voltage-clamp
mode at 80 mV.
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